688073.SS Stock Analysis
68
Uncovered
Bide Pharmatech Co Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.623
Dividend yield
2.93 %
Shares outstanding
64.916 B
Bide Pharmatech Co Ltd is a CN-based company operating in industry. The company is headquartered in Shanghai, Shanghai and currently employs 534 full-time employees. The company went IPO on 2022-10-11. Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The firm's main businesses are the research, development, design, production and sales of drug molecular building blocks. The firm's main products are pharmaceutical molecular building blocks and scientific reagents. The firm's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The firm conducts business in Asia Pacific, India, Europe, the United States and other regions.